Biotechnology
The Biotechnology industry has a total of 644 stocks, with a combined market cap of $827.77 billion and total revenue of $98.24 billion.
Market Cap
827.77B
Revenue
98.24B
Profits
-45.23B
PE Ratio
n/a
Profit Margin
-46.04%
Dividend Yield
0.05%
644 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.36B | 1.08% | 978,178 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 57.88B | 2.40% | 818,002 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.00B | 2.39% | 963,249 | 2.35B |
| 4 | ARGX | argenx SE | 33.64B | 0.49% | 543,093 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 28.93B | -0.54% | 353,158 | 4.18B |
| 6 | BNTX | BioNTech SE | 26.66B | 0.70% | 998,621 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 20.35B | 0.86% | 3,858,570 | 2.26B |
| 8 | INSM | Insmed Incorporated | 18.66B | 0.64% | 3,291,847 | 381.03M |
| 9 | SMMT | Summit Therapeutics Inc. | 16.80B | 6.70% | 3,808,358 | - |
| 10 | INCY | Incyte Corporation | 13.20B | -0.81% | 2,374,337 | 4.41B |
| 11 | GMAB | Genmab A/S | 12.58B | -1.45% | 1,310,145 | 3.23B |
| 12 | EXEL | Exelixis, Inc. | 12.08B | 1.56% | 3,071,181 | 2.30B |
| 13 | MRNA | Moderna, Inc. | 11.71B | 5.54% | 14,708,619 | 3.18B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 10.96B | 1.74% | 2,986,830 | 2.95B |
| 15 | ASND | Ascendis Pharma A/S | 10.48B | 0.64% | 270,610 | 398.51M |
| 16 | TECH | Bio-Techne Corporation | 8.34B | 2.11% | 1,805,393 | 1.21B |
| 17 | BPMC | Blueprint Medicines Corporation | 8.30B | -0.11% | 2,277,246 | 562.12M |
| 18 | VRNA | Verona Pharma plc | 8.21B | -0.44% | 962,449 | 118.54M |
| 19 | BBIO | BridgeBio Pharma, Inc. | 8.13B | 0.12% | 2,570,381 | 127.42M |
| 20 | CORT | Corcept Therapeutics Incorporated | 7.57B | 2.93% | 1,154,883 | 685.45M |
| 21 | ROIV | Roivant Sciences Ltd. | 7.46B | 0.27% | 11,020,081 | 29.05M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.43B | 0.79% | 467,287 | 452.50M |
| 23 | IONS | Ionis Pharmaceuticals, Inc. | 6.94B | 9.14% | 4,259,137 | 717.25M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.93B | 0.80% | 1,781,606 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.67B | 0.12% | 340,855 | 317.38M |
| 26 | JAZZ | Jazz Pharmaceuticals plc | 6.65B | 0.44% | 770,393 | 4.06B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 6.63B | 1.74% | 2,214,891 | 1.08B |
| 28 | LEGN | Legend Biotech Corporation | 6.62B | -1.05% | 1,134,810 | 728.30M |
| 29 | NUVL | Nuvalent, Inc. | 5.78B | 3.19% | 493,355 | - |
| 30 | TLX | Telix Pharmaceuticals Limited | 5.50B | 2.61% | 58,710 | 484.69M |
| 31 | TGTX | TG Therapeutics, Inc. | 5.29B | 2.51% | 1,385,357 | 386.39M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 5.13B | 0.91% | 399,405 | 432.16M |
| 33 | CRSP | CRISPR Therapeutics AG | 4.74B | 6.51% | 3,365,361 | 37.68M |
| 34 | SLNO | Soleno Therapeutics, Inc. | 4.34B | 4.30% | 971,849 | - |
| 35 | ADMA | ADMA Biologics, Inc. | 4.33B | 1.45% | 3,086,568 | 459.38M |
| 36 | PCVX | Vaxcyte, Inc. | 4.29B | 1.00% | 1,402,932 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 4.26B | 2.26% | 963,028 | 136.86M |
| 38 | AKRO | Akero Therapeutics, Inc. | 4.14B | 1.04% | 813,363 | - |
| 39 | CYTK | Cytokinetics, Incorporated | 4.10B | 2.14% | 1,313,822 | 19.22M |
| 40 | KRYS | Krystal Biotech, Inc. | 4.08B | 1.68% | 209,859 | 333.45M |
| 41 | MRUS | Merus N.V. | 3.97B | 1.27% | 526,903 | 54.73M |
| 42 | ZLAB | Zai Lab Limited | 3.92B | 0.91% | 424,192 | 418.33M |
| 43 | PTCT | PTC Therapeutics, Inc. | 3.90B | 1.15% | 1,060,210 | 1.77B |
| 44 | RARE | Ultragenyx Pharmaceutical Inc. | 3.72B | 8.83% | 1,815,184 | 590.69M |
| 45 | ACLX | Arcellx, Inc. | 3.66B | 2.40% | 493,407 | 76.81M |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 3.55B | -0.56% | 2,064,291 | 996.28M |
| 47 | SWTX | SpringWorks Therapeutics, Inc. | 3.54B | - | - | 219.67M |
| 48 | RNA | Avidity Biosciences, Inc. | 3.54B | 3.16% | 828,140 | 8.93M |
| 49 | AAPG | Ascentage Pharma Group International | 3.41B | 2.21% | 5,607 | 134.35M |
| 50 | SRRK | Scholar Rock Holding Corporation | 3.38B | 5.30% | 1,027,199 | - |
| 51 | PTGX | Protagonist Therapeutics, Inc. | 3.14B | 0.96% | 1,209,144 | 207.80M |
| 52 | KYMR | Kymera Therapeutics, Inc. | 3.12B | 0.20% | 990,465 | 58.89M |
| 53 | VKTX | Viking Therapeutics, Inc. | 3.11B | 3.94% | 4,100,862 | - |
| 54 | MLTX | MoonLake Immunotherapeutics | 3.04B | 2.68% | 425,800 | - |
| 55 | MTSR | Metsera, Inc. | 3.03B | 7.37% | 1,157,377 | - |
| 56 | IMVT | Immunovant, Inc. | 2.87B | 4.09% | 1,061,672 | - |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.76B | 3.55% | 866,900 | 760.00K |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.62B | 1.23% | 984,130 | 534.65M |
| 59 | APGE | Apogee Therapeutics, Inc. | 2.59B | 0.14% | 1,371,562 | - |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 2.56B | 3.99% | 1,280,124 | 7.50M |
| 61 | MIRM | Mirum Pharmaceuticals, Inc. | 2.43B | 1.45% | 461,903 | 379.25M |
| 62 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.33B | 5.03% | 1,741,253 | 545.21M |
| 63 | IBRX | ImmunityBio, Inc. | 2.33B | 2.72% | 6,770,763 | 31.22M |
| 64 | APLS | Apellis Pharmaceuticals, Inc. | 2.24B | -0.28% | 1,810,589 | 775.84M |
| 65 | LGND | Ligand Pharmaceuticals Incorporated | 2.19B | 0.66% | 106,477 | 181.49M |
| 66 | DNLI | Denali Therapeutics Inc. | 2.16B | 6.81% | 1,707,316 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 2.13B | 4.06% | 1,178,001 | 47.14M |
| 68 | RXRX | Recursion Pharmaceuticals, Inc. | 2.12B | 1.56% | 25,071,565 | 59.79M |
| 69 | VCEL | Vericel Corporation | 2.08B | -0.67% | 405,270 | 238.54M |
| 70 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 2.85% | 566,223 | 37.04M |
| 71 | CGON | CG Oncology, Inc. | 2.03B | 1.40% | 772,557 | 662.00K |
| 72 | BEAM | Beam Therapeutics Inc. | 1.94B | 13.41% | 4,003,942 | 63.58M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 1.92B | 3.84% | 1,014,023 | 7.00M |
| 74 | GLPG | Galapagos NV | 1.89B | 2.48% | 143,579 | 311.49M |
| 75 | BLTE | Belite Bio, Inc | 1.85B | -0.61% | 114,550 | - |
| 76 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | 0.28% | 379,075 | 744.85M |
| 77 | IRON | Disc Medicine, Inc. | 1.84B | 3.99% | 501,327 | - |
| 78 | FOLD | Amicus Therapeutics, Inc. | 1.83B | 1.88% | 3,866,154 | 543.14M |
| 79 | CNTA | Centessa Pharmaceuticals plc | 1.83B | 4.10% | 651,586 | 15.00M |
| 80 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 2.74% | 4,644,372 | 2.23B |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 1.74B | 2.59% | 1,608,166 | 189.53M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 1.70B | 1.15% | 403,504 | 233.67M |
| 83 | IMCR | Immunocore Holdings plc | 1.65B | -0.27% | 456,167 | 333.58M |
| 84 | SPRY | ARS Pharmaceuticals, Inc. | 1.65B | 4.10% | 1,284,450 | 97.12M |
| 85 | ARQT | Arcutis Biotherapeutics, Inc. | 1.64B | 0.07% | 1,654,756 | 212.82M |
| 86 | VERA | Vera Therapeutics, Inc. | 1.51B | 2.83% | 1,320,561 | - |
| 87 | BHVN | Biohaven Ltd. | 1.51B | 5.73% | 2,211,138 | - |
| 88 | OCUL | Ocular Therapeutix, Inc. | 1.51B | 3.96% | 3,087,555 | 59.65M |
| 89 | ETNB | 89bio, Inc. | 1.47B | 3.80% | 2,040,436 | - |
| 90 | CLDX | Celldex Therapeutics, Inc. | 1.47B | 4.24% | 1,642,250 | 7.56M |
| 91 | JANX | Janux Therapeutics, Inc. | 1.42B | 3.62% | 632,135 | 9.34M |
| 92 | MESO | Mesoblast Limited | 1.41B | -10.40% | 384,835 | 5.67M |
| 93 | EWTX | Edgewise Therapeutics, Inc. | 1.37B | 1.48% | 494,207 | - |
| 94 | TVTX | Travere Therapeutics, Inc. | 1.32B | 0.85% | 1,368,975 | 273.53M |
| 95 | VRDN | Viridian Therapeutics, Inc. | 1.24B | 5.25% | 895,698 | 302.00K |
| 96 | INVA | Innoviva, Inc. | 1.22B | -1.97% | 887,054 | 369.84M |
| 97 | ELVN | Enliven Therapeutics, Inc. | 1.22B | 5.09% | 947,025 | - |
| 98 | CVAC | CureVac N.V. | 1.22B | -0.18% | 655,721 | 566.04M |
| 99 | GPCR | Structure Therapeutics Inc. | 1.18B | -0.34% | 487,278 | - |
| 100 | ABCL | AbCellera Biologics Inc. | 1.12B | 7.45% | 8,663,641 | 23.11M |
| 101 | NTLA | Intellia Therapeutics, Inc. | 1.11B | 8.60% | 7,234,107 | 45.57M |
| 102 | MNKD | MannKind Corporation | 1.10B | 1.12% | 3,250,397 | 297.60M |
| 103 | NVAX | Novavax, Inc. | 1.09B | 2.27% | 5,479,389 | 1.25B |
| 104 | CDTX | Cidara Therapeutics, Inc. | 1.06B | -2.37% | 1,157,993 | 302.00K |
| 105 | OCS | Oculis Holding AG | 1.04B | 0.05% | 12,263 | 847.33K |
| 106 | WVE | Wave Life Sciences Ltd. | 1.04B | 3.60% | 947,866 | 104.94M |
| 107 | LQDA | Liquidia Corporation | 1.03B | 0.50% | 1,479,502 | 14.14M |
| 108 | DYN | Dyne Therapeutics, Inc. | 1.02B | 3.00% | 5,538,727 | - |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 1.01B | 0.13% | 2,249,154 | 247.30M |
| 110 | ARDX | Ardelyx, Inc. | 1.00B | 7.44% | 8,063,734 | 361.71M |
| 111 | VERV | Verve Therapeutics, Inc. | 1.00B | -0.62% | 3,180,776 | 59.61M |
| 112 | NAGE | Niagen Bioscience, Inc. | 993.02M | -1.80% | 1,003,311 | 107.93M |
| 113 | PHVS | Pharvaris N.V. | 971.07M | 3.30% | 10,150 | - |
| 114 | ZYME | Zymeworks Inc. | 964.75M | 3.87% | 288,511 | 93.38M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 948.37M | 6.23% | 779,716 | 56.42M |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 943.49M | 7.30% | 243,796 | 8.12M |
| 117 | SYRE | Spyre Therapeutics, Inc. | 935.48M | -0.16% | 617,590 | - |
| 118 | GHRS | GH Research PLC | 932.28M | 18.16% | 411,150 | - |
| 119 | MLYS | Mineralys Therapeutics, Inc. | 931.35M | 4.31% | 753,723 | - |
| 120 | SION | Sionna Therapeutics, Inc. | 920.20M | 14.92% | 440,092 | - |
| 121 | MDXG | MiMedx Group, Inc. | 920.18M | 0.16% | 664,142 | 352.38M |
| 122 | RCUS | Arcus Biosciences, Inc. | 909.55M | 2.75% | 710,243 | 141.00M |
| 123 | ORIC | ORIC Pharmaceuticals, Inc. | 907.64M | 5.03% | 776,090 | - |
| 124 | AVXL | Anavex Life Sciences Corp. | 902.38M | 13.29% | 1,468,284 | - |
| 125 | GERN | Geron Corporation | 891.68M | 1.45% | 10,320,215 | 116.29M |
| 126 | LENZ | LENZ Therapeutics, Inc. | 871.12M | 3.00% | 161,449 | - |
| 127 | CRMD | CorMedix Inc. | 862.63M | -1.70% | 1,985,776 | 82.55M |
| 128 | COGT | Cogent Biosciences, Inc. | 844.25M | 2.63% | 1,778,424 | - |
| 129 | QURE | uniQure N.V. | 781.81M | 2.07% | 804,612 | 20.20M |
| 130 | SNDX | Syndax Pharmaceuticals, Inc. | 774.43M | 2.04% | 1,789,112 | 43.72M |
| 131 | XERS | Xeris Biopharma Holdings, Inc. | 757.53M | 1.50% | 1,473,634 | 222.55M |
| 132 | IMNM | Immunome, Inc. | 750.92M | 1.89% | 1,378,103 | 10.94M |
| 133 | VIR | Vir Biotechnology, Inc. | 750.63M | 6.26% | 1,390,744 | 20.86M |
| 134 | DNA | Ginkgo Bioworks Holdings, Inc. | 741.01M | 11.44% | 1,843,924 | 237.42M |
| 135 | REPL | Replimune Group, Inc. | 736.18M | 4.37% | 1,375,847 | - |
| 136 | AVBP | ArriVent BioPharma, Inc. | 721.89M | 1.05% | 948,974 | - |
| 137 | PHAR | Pharming Group N.V. | 721.22M | -0.56% | 2,238 | 320.71M |
| 138 | TRVI | Trevi Therapeutics, Inc. | 712.49M | 4.91% | 2,843,783 | - |
| 139 | GYRE | Gyre Therapeutics, Inc. | 707.12M | 4.56% | 134,729 | 100.64M |
| 140 | ANAB | AnaptysBio, Inc. | 701.61M | 5.43% | 614,654 | 111.87M |
| 141 | NUVB | Nuvation Bio Inc. | 697.54M | 5.67% | 4,695,309 | 10.96M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 682.17M | 1.82% | 1,459,238 | 161.92M |
| 143 | IMTX | Immatics N.V. | 679.47M | 0.90% | 319,223 | 155.80M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 674.85M | 5.58% | 1,970,436 | 241.86M |
| 145 | EYPT | EyePoint Pharmaceuticals, Inc. | 664.72M | 1.15% | 769,796 | 56.04M |
| 146 | SANA | Sana Biotechnology, Inc. | 658.62M | 3.18% | 7,685,572 | - |
| 147 | STOK | Stoke Therapeutics, Inc. | 630.59M | -0.86% | 403,397 | 190.91M |
| 148 | AUTL | Autolus Therapeutics plc | 625.43M | 2.62% | 1,571,276 | 9.01M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 620.57M | 0.68% | 1,824,159 | 81.86M |
| 150 | RLAY | Relay Therapeutics, Inc. | 617.20M | 2.27% | 1,541,706 | 7.68M |
| 151 | TNGX | Tango Therapeutics, Inc. | 612.43M | 3.86% | 1,749,131 | 40.99M |
| 152 | ABUS | Arbutus Biopharma Corporation | 610.97M | 0.31% | 599,477 | 6.40M |
| 153 | UPB | Upstream Bio, Inc. | 598.72M | 3.15% | 220,823 | 2.30M |
| 154 | URGN | UroGen Pharma Ltd. | 597.55M | -0.46% | 1,845,308 | 91.87M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 591.74M | 2.45% | 675,241 | 6.52M |
| 156 | XNCR | Xencor, Inc. | 590.72M | 2.85% | 913,707 | 127.23M |
| 157 | AMLX | Amylyx Pharmaceuticals, Inc. | 585.66M | 2.50% | 2,023,106 | -1.27M |
| 158 | KALV | KalVista Pharmaceuticals, Inc. | 585.65M | 1.64% | 755,310 | - |
| 159 | IOVA | Iovance Biotherapeutics, Inc. | 584.39M | 0.57% | 6,755,473 | 212.68M |
| 160 | ATAI | Atai Life Sciences N.V. | 583.40M | 1.48% | 11,747,230 | 1.86M |
| 161 | ARVN | Arvinas, Inc. | 576.63M | 3.54% | 1,981,744 | 426.90M |
| 162 | SAGE | Sage Therapeutics, Inc. | 568.61M | - | 1,482,653 | 47.40M |
| 163 | MGTX | MeiraGTx Holdings plc | 556.13M | 6.79% | 546,663 | 34.51M |
| 164 | TBPH | Theravance Biopharma, Inc. | 552.51M | 1.19% | 169,970 | 65.27M |
| 165 | KROS | Keros Therapeutics, Inc. | 544.65M | 0.75% | 414,582 | 214.71M |
| 166 | MNMD | Mind Medicine (MindMed) Inc. | 534.92M | 5.99% | 1,252,027 | - |
| 167 | TYRA | Tyra Biosciences, Inc. | 534.44M | 3.40% | 609,973 | - |
| 168 | TSHA | Taysha Gene Therapies, Inc. | 521.63M | 3.85% | 2,757,135 | 7.22M |
| 169 | MAZE | Maze Therapeutics, Inc. | 519.43M | 1.72% | 121,108 | 167.50M |
| 170 | BCYC | Bicycle Therapeutics plc | 515.25M | 5.83% | 909,578 | 25.72M |
| 171 | ZVRA | Zevra Therapeutics, Inc. | 514.54M | 5.14% | 1,585,071 | 40.59M |
| 172 | ABVX | ABIVAX Société Anonyme | 512.74M | 1.31% | 206,620 | 11.44M |
| 173 | SEPN | Septerna, Inc. | 507.97M | 7.55% | 751,488 | 977.00K |
| 174 | KURA | Kura Oncology, Inc. | 503.00M | 3.75% | 1,552,634 | 67.99M |
| 175 | BCAX | Bicara Therapeutics Inc. | 501.73M | -2.75% | 493,453 | - |
| 176 | CELC | Celcuity Inc. | 493.78M | 4.40% | 231,366 | - |
| 177 | VALN | Valneva SE | 480.23M | 1.57% | 6,504 | 201.10M |
| 178 | PGEN | Precigen, Inc. | 475.24M | 11.03% | 3,913,770 | 4.20M |
| 179 | ORKA | Oruka Therapeutics, Inc. | 472.12M | 7.63% | 249,915 | - |
| 180 | ATYR | aTyr Pharma, Inc. | 469.94M | 2.92% | 4,545,904 | 235.00K |
| 181 | FTRE | Fortrea Holdings Inc. | 468.09M | -0.77% | 1,743,876 | 2.69B |
| 182 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 183 | CAPR | Capricor Therapeutics, Inc. | 457.99M | 3.30% | 1,266,219 | 17.36M |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 457.95M | 1.44% | 319,804 | - |
| 185 | MREO | Mereo BioPharma Group plc | 456.33M | 3.99% | 836,455 | 1.00M |
| 186 | SVRA | Savara Inc. | 442.45M | 2.44% | 1,084,659 | - |
| 187 | RGNX | REGENXBIO Inc. | 434.35M | 4.74% | 851,816 | 156.72M |
| 188 | RAPP | Rapport Therapeutics, Inc. | 430.67M | 4.69% | 188,192 | - |
| 189 | ZBIO | Zenas BioPharma, Inc. | 427.75M | 11.87% | 194,408 | 15.00M |
| 190 | IVA | Inventiva S.A. | 421.34M | - | 7,137 | 14.59M |
| 191 | TRML | Tourmaline Bio, Inc. | 415.90M | 2.24% | 153,949 | - |
| 192 | RZLT | Rezolute, Inc. | 415.62M | 9.95% | 1,072,013 | - |
| 193 | PRTC | PureTech Health plc | 414.72M | -0.23% | 477 | 4.83M |
| 194 | MBX | MBX Biosciences, Inc. | 412.12M | 6.20% | 425,670 | - |
| 195 | ERAS | Erasca, Inc. | 410.77M | 6.62% | 1,943,248 | - |
| 196 | AURA | Aura Biosciences, Inc. | 400.55M | 3.19% | 198,071 | - |
| 197 | ALT | Altimmune, Inc. | 397.42M | 15.84% | 14,705,162 | 20.00K |
| 198 | TECX | Tectonic Therapeutic, Inc. | 393.80M | 5.11% | 113,563 | - |
| 199 | PRME | Prime Medicine, Inc. | 392.41M | 12.45% | 6,702,033 | 3.85M |
| 200 | CTMX | CytomX Therapeutics, Inc. | 390.71M | 5.08% | 783,816 | 147.56M |
| 201 | ITOS | iTeos Therapeutics, Inc. | 388.86M | 1.60% | 669,588 | 35.00M |
| 202 | SLDB | Solid Biosciences Inc. | 377.50M | 5.87% | 1,105,736 | - |
| 203 | FULC | Fulcrum Therapeutics, Inc. | 374.62M | 1.46% | 381,940 | 80.00M |
| 204 | VIGL | Vigil Neuroscience, Inc. | 372.44M | 0.19% | 559,280 | - |
| 205 | TERN | Terns Pharmaceuticals, Inc. | 372.06M | 10.65% | 887,886 | - |
| 206 | ARCT | Arcturus Therapeutics Holdings Inc. | 369.38M | 4.85% | 590,239 | 143.68M |
| 207 | CMPX | Compass Therapeutics, Inc. | 362.30M | 1.55% | 779,320 | 850.00K |
| 208 | HUMA | Humacyte, Inc. | 358.32M | 1.32% | 2,757,725 | 517.00K |
| 209 | JBIO | Jade Biosciences, Inc. | 348.15M | -0.46% | 197,514 | - |
| 210 | ABSI | Absci Corporation | 343.13M | 3.86% | 3,226,682 | 4.82M |
| 211 | PRTA | Prothena Corporation plc | 339.92M | 0.88% | 1,114,509 | 137.94M |
| 212 | BNTC | Benitec Biopharma Inc. | 334.43M | 5.20% | 144,536 | - |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 333.32M | -0.32% | 217,446 | 203.08M |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 332.63M | 3.60% | 2,814,252 | 31.21M |
| 215 | HRTX | Heron Therapeutics, Inc. | 328.01M | -0.92% | 2,491,915 | 148.52M |
| 216 | ATXS | Astria Therapeutics, Inc. | 323.37M | 5.71% | 218,523 | - |
| 217 | XOMA | XOMA Royalty Corporation | 320.11M | 1.56% | 69,261 | 42.91M |
| 218 | NKTR | Nektar Therapeutics | 316.75M | 3.82% | 2,076,396 | 87.25M |
| 219 | OLMA | Olema Pharmaceuticals, Inc. | 310.63M | 3.66% | 613,166 | - |
| 220 | RCKT | Rocket Pharmaceuticals, Inc. | 310.29M | 11.20% | 5,605,887 | - |
| 221 | AVIR | Atea Pharmaceuticals, Inc. | 310.23M | 0.69% | 493,062 | - |
| 222 | ANNX | Annexon, Inc. | 308.30M | 13.77% | 3,089,363 | - |
| 223 | CRVS | Corvus Pharmaceuticals, Inc. | 306.92M | 3.11% | 728,120 | - |
| 224 | AARD | Aardvark Therapeutics, Inc. | 301.36M | 2.43% | 41,788 | - |
| 225 | ABEO | Abeona Therapeutics Inc. | 300.29M | 5.39% | 1,379,286 | - |
| 226 | RNAC | Cartesian Therapeutics, Inc. | 295.10M | 4.78% | 49,808 | 34.17M |
| 227 | GLUE | Monte Rosa Therapeutics, Inc. | 290.63M | 2.49% | 298,476 | 159.49M |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 288.19M | 4.49% | 339,319 | 201.35M |
| 229 | NGNE | Neurogene Inc. | 281.68M | 2.92% | 240,583 | 925.00K |
| 230 | ADCT | ADC Therapeutics SA | 277.70M | 4.87% | 663,056 | 75.82M |
| 231 | FHTX | Foghorn Therapeutics Inc. | 275.92M | 2.26% | 171,832 | 23.50M |
| 232 | GOSS | Gossamer Bio, Inc. | 275.04M | -3.20% | 1,177,882 | 124.59M |
| 233 | OCGN | Ocugen, Inc. | 270.54M | 0.25% | 3,474,814 | 4.52M |
| 234 | DBVT | DBV Technologies S.A. | 269.88M | -0.67% | 61,654 | 3.50M |
| 235 | SLN | Silence Therapeutics plc | 268.74M | -3.89% | 84,389 | 27.70M |
| 236 | DRTS | Alpha Tau Medical Ltd. | 268.50M | 0.96% | 12,793 | - |
| 237 | VSTM | Verastem, Inc. | 266.50M | 13.05% | 5,315,931 | 10.00M |
| 238 | ALLO | Allogene Therapeutics, Inc. | 262.48M | 1.69% | 4,809,985 | 22.00K |
| 239 | PVLA | Palvella Therapeutics, Inc. | 262.02M | 4.54% | 79,132 | - |
| 240 | SGMT | Sagimet Biosciences Inc. | 261.10M | 1.00% | 543,546 | - |
| 241 | TNXP | Tonix Pharmaceuticals Holding Corp. | 260.47M | -5.71% | 664,388 | 10.04M |
| 242 | INZY | Inozyme Pharma, Inc. | 259.66M | - | - | - |
| 243 | TRDA | Entrada Therapeutics, Inc. | 256.32M | 2.25% | 126,278 | 172.22M |
| 244 | CADL | Candel Therapeutics, Inc. | 250.01M | 2.89% | 913,732 | - |
| 245 | THRD | Third Harmonic Bio, Inc. | 244.59M | 0.09% | 284,851 | - |
| 246 | ALDX | Aldeyra Therapeutics, Inc. | 239.58M | 1.78% | 1,504,505 | - |
| 247 | CRDF | Cardiff Oncology, Inc. | 238.83M | 2.28% | 1,408,714 | 587.00K |
| 248 | FENC | Fennec Pharmaceuticals Inc. | 237.52M | 3.61% | 114,106 | 30.91M |
| 249 | LXEO | Lexeo Therapeutics, Inc. | 235.97M | 3.55% | 264,314 | - |
| 250 | NBTX | Nanobiotix S.A. | 233.34M | 0.31% | 630 | -7.44M |
| 251 | LCTX | Lineage Cell Therapeutics, Inc. | 232.92M | 13.62% | 2,527,058 | 9.56M |
| 252 | CDXS | Codexis, Inc. | 232.79M | 17.08% | 1,471,200 | 49.82M |
| 253 | CBIO | Crescent Biopharma, Inc. | 232.46M | -5.51% | 106,451 | - |
| 254 | TVGN | Tevogen Bio Holdings Inc. | 230.55M | 2.46% | 282,852 | - |
| 255 | IMMP | Immutep Limited | 230.25M | 3.03% | 62,548 | 3.02M |
| 256 | LIMN | Liminatus Pharma, Inc. | 229.19M | -14.88% | 285,383 | - |
| 257 | INBX | Inhibrx Biosciences, Inc. | 227.85M | 7.36% | 78,764 | 200.00K |
| 258 | OABI | OmniAb, Inc. | 227.54M | 7.18% | 383,271 | 26.74M |
| 259 | TENX | Tenax Therapeutics, Inc. | 226.25M | -0.87% | 19,982 | - |
| 260 | PRQR | ProQR Therapeutics N.V. | 224.38M | 5.97% | 342,246 | 21.21M |
| 261 | MNPR | Monopar Therapeutics Inc. | 215.01M | 4.77% | 60,923 | - |
| 262 | EDIT | Editas Medicine, Inc. | 214.30M | 13.78% | 9,568,174 | 35.84M |
| 263 | SCPH | scPharmaceuticals Inc. | 213.81M | 3.32% | 317,939 | 41.98M |
| 264 | SLS | SELLAS Life Sciences Group, Inc. | 211.53M | 1.92% | 3,338,570 | - |
| 265 | DSGN | Design Therapeutics, Inc. | 208.91M | 4.55% | 139,298 | - |
| 266 | MDWD | MediWound Ltd. | 206.64M | -0.60% | 40,344 | 19.21M |
| 267 | CRGX | CARGO Therapeutics, Inc. | 202.67M | 4.89% | 325,034 | - |
| 268 | KOD | Kodiak Sciences Inc. | 201.57M | 1.86% | 338,975 | - |
| 269 | TVRD | Tvardi Therapeutics, Inc. | 200.79M | -3.16% | 36,466 | - |
| 270 | FDMT | 4D Molecular Therapeutics, Inc. | 199.66M | 3.86% | 620,596 | 23.00K |
| 271 | LRMR | Larimar Therapeutics, Inc. | 199.13M | 7.99% | 877,299 | - |
| 272 | ACIU | AC Immune SA | 195.91M | - | 108,131 | 32.01M |
| 273 | GNFT | Genfit S.A. | 195.50M | 2.64% | 732 | 73.19M |
| 274 | EPRX | Eupraxia Pharmaceuticals Inc. | 195.41M | -5.31% | 12,352 | - |
| 275 | YMAB | Y-mAbs Therapeutics, Inc. | 192.96M | -3.40% | 143,375 | 88.66M |
| 276 | ENGN | enGene Holdings Inc. | 191.13M | 3.31% | 104,384 | - |
| 277 | ENGNW | enGene Holdings Inc. | 191.13M | 24.46% | 8,219 | - |
| 278 | DRUG | Bright Minds Biosciences Inc. | 187.33M | 5.38% | 93,984 | - |
| 279 | IMAB | I-Mab | 187.00M | -2.14% | 485,301 | 569.46K |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 183.24M | 9.68% | 509,757 | - |
| 281 | VOR | Vor Biopharma Inc. | 181.19M | 1.40% | 25,303,020 | - |
| 282 | OMER | Omeros Corporation | 181.05M | 4.04% | 1,357,605 | - |
| 283 | ALMS | Alumis Inc. | 178.45M | 8.61% | 1,265,986 | 17.39M |
| 284 | NVCT | Nuvectis Pharma, Inc. | 177.38M | 2.67% | 72,170 | - |
| 285 | PBYI | Puma Biotechnology, Inc. | 177.21M | -0.56% | 244,222 | 232.71M |
| 286 | VYGR | Voyager Therapeutics, Inc. | 177.08M | 2.56% | 656,229 | 66.96M |
| 287 | TLSA | Tiziana Life Sciences Ltd | 175.00M | 1.29% | 118,064 | - |
| 288 | ACOG | Alpha Cognition Inc. | 171.25M | 16.20% | 155,406 | 2.93M |
| 289 | ENTA | Enanta Pharmaceuticals, Inc. | 170.37M | 3.83% | 209,818 | 64.46M |
| 290 | PROK | ProKidney Corp. | 169.39M | 2.39% | 460,660 | 306.00K |
| 291 | FBRX | Forte Biosciences, Inc. | 169.04M | 11.25% | 129,928 | - |
| 292 | IPHA | Innate Pharma S.A. | 164.96M | -1.36% | 5,448 | 20.83M |
| 293 | CGEN | Compugen Ltd. | 162.71M | 0.58% | 146,001 | 27.59M |
| 294 | SPRO | Spero Therapeutics, Inc. | 162.14M | - | 1,098,105 | 44.58M |
| 295 | ACRS | Aclaris Therapeutics, Inc. | 157.01M | 2.84% | 733,024 | 17.78M |
| 296 | TIL | Instil Bio, Inc. | 156.19M | 8.57% | 319,823 | - |
| 297 | CYBN | Cybin Inc. | 155.25M | -18.00% | 1,336,434 | - |
| 298 | DMAC | DiaMedica Therapeutics Inc. | 154.38M | 0.84% | 291,529 | - |
| 299 | AGEN | Agenus Inc. | 151.07M | 13.84% | 1,119,305 | 99.52M |
| 300 | ALEC | Alector, Inc. | 149.99M | 6.34% | 422,474 | 88.34M |
| 301 | BDTX | Black Diamond Therapeutics, Inc. | 147.84M | 4.84% | 1,399,026 | 70.00M |
| 302 | CABA | Cabaletta Bio, Inc. | 143.91M | 2.56% | 2,059,310 | - |
| 303 | VTYX | Ventyx Biosciences, Inc. | 143.75M | -2.18% | 2,433,239 | - |
| 304 | CUPR | Cuprina Holdings (Cayman) Limited | 143.29M | 1.21% | 500,097 | 35.41K |
| 305 | MOLN | Molecular Partners AG | 141.41M | 2.43% | 638 | 2.53M |
| 306 | ASMB | Assembly Biosciences, Inc. | 139.77M | 3.21% | 49,285 | 32.15M |
| 307 | LYEL | Lyell Immunopharma, Inc. | 139.20M | -0.32% | 74,059 | 65.00K |
| 308 | IKT | Inhibikase Therapeutics, Inc. | 137.53M | -5.13% | 137,915 | 1.00 |
| 309 | GALT | Galectin Therapeutics Inc. | 137.34M | -2.25% | 272,008 | - |
| 310 | RAPT | RAPT Therapeutics, Inc. | 132.45M | 9.28% | 50,877 | - |
| 311 | ACTU | Actuate Therapeutics, Inc. | 132.24M | 9.95% | 131,089 | - |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 132.08M | 9.17% | 73,568 | - |
| 313 | SEER | Seer, Inc. | 130.05M | 0.91% | 148,576 | 15.31M |
| 314 | SKYE | Skye Bioscience, Inc. | 129.20M | 11.50% | 871,329 | - |
| 315 | IMRX | Immuneering Corporation | 129.19M | 4.36% | 708,065 | - |
| 316 | FATE | Fate Therapeutics, Inc. | 128.39M | -1.75% | 2,663,447 | 13.34M |
| 317 | MIST | Milestone Pharmaceuticals Inc. | 127.44M | 2.13% | 351,644 | - |
| 318 | CRBU | Caribou Biosciences, Inc. | 127.42M | 9.60% | 1,515,725 | 9.92M |
| 319 | SGMO | Sangamo Therapeutics, Inc. | 127.12M | -0.22% | 6,685,500 | 63.76M |
| 320 | NMRA | Neumora Therapeutics, Inc. | 126.52M | -1.77% | 1,136,621 | - |
| 321 | ELTX | Elicio Therapeutics, Inc. | 125.46M | 1.42% | 46,393 | - |
| 322 | NKTX | Nkarta, Inc. | 123.47M | 1.75% | 330,243 | - |
| 323 | KRRO | Korro Bio, Inc. | 122.92M | 2.51% | 104,378 | 4.82M |
| 324 | KYTX | Kyverna Therapeutics, Inc. | 122.31M | 2.17% | 637,634 | - |
| 325 | HURA | TuHURA Biosciences, Inc. | 121.49M | 5.67% | 599,753 | - |
| 326 | PLX | Protalix BioTherapeutics, Inc. | 119.41M | 1.35% | 546,566 | 59.76M |
| 327 | NTRB | Nutriband Inc. | 119.32M | 33.67% | 1,780,511 | 2.40M |
| 328 | ACHV | Achieve Life Sciences, Inc. | 116.28M | 1.80% | 1,191,862 | - |
| 329 | CLLS | Cellectis S.A. | 115.43M | 6.45% | 98,551 | 54.75M |
| 330 | OBIO | Orchestra BioMed Holdings, Inc. | 110.34M | 3.97% | 116,083 | 2.89M |
| 331 | OKYO | OKYO Pharma Limited | 108.90M | 11.49% | 72,082 | - |
| 332 | THTX | Theratechnologies Inc. | 108.28M | 2.61% | 60,889 | 88.67M |
| 333 | ATOS | Atossa Therapeutics, Inc. | 108.13M | 1.57% | 543,369 | - |
| 334 | CCCC | C4 Therapeutics, Inc. | 107.93M | 0.66% | 1,765,652 | 39.78M |
| 335 | VTVT | vTv Therapeutics Inc. | 107.91M | 2.66% | 4,615 | 17.00K |
| 336 | TARA | Protara Therapeutics, Inc. | 107.26M | -0.71% | 338,157 | - |
| 337 | CSBR | Champions Oncology, Inc. | 106.50M | 7.77% | 11,998 | 58.59M |
| 338 | GNLX | Genelux Corporation | 105.94M | 0.35% | 48,265 | 8.00K |
| 339 | HLVX | HilleVax, Inc. | 104.67M | 4.46% | 259,034 | - |
| 340 | CTNM | Contineum Therapeutics, Inc. | 102.84M | 3.25% | 282,825 | - |
| 341 | ANIX | Anixa Biosciences, Inc. | 102.75M | -1.24% | 94,038 | - |
| 342 | JSPR | Jasper Therapeutics, Inc. | 102.45M | 18.82% | 688,266 | - |
| 343 | NTHI | NeOnc Technologies Holdings, Inc. | 100.65M | 57.91% | 281,944 | 79.99K |
| 344 | VXRT | Vaxart, Inc. | 99.96M | -4.74% | 3,672,418 | 47.40M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 99.68M | 1.63% | 1,511,960 | - |
| 346 | NAUT | Nautilus Biotechnology, Inc. | 98.77M | 7.26% | 132,940 | - |
| 347 | XBIT | XBiotech Inc. | 98.48M | 1.89% | 52,309 | - |
| 348 | IOBT | IO Biotech, Inc. | 98.16M | 7.97% | 206,831 | - |
| 349 | SAVA | Cassava Sciences, Inc. | 97.10M | 8.65% | 1,292,598 | - |
| 350 | COYA | Coya Therapeutics, Inc. | 96.67M | 1.40% | 76,554 | 3.69M |
| 351 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 94.83M | 8.24% | 270,594 | - |
| 352 | MCRB | Seres Therapeutics, Inc. | 94.83M | 1.68% | 59,696 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 94.09M | -4.07% | 1,601,231 | - |
| 354 | BYSI | BeyondSpring Inc. | 92.73M | -4.96% | 16,647 | 1.88M |
| 355 | CHRS | Coherus Oncology, Inc. | 92.18M | 4.58% | 1,273,813 | 272.25M |
| 356 | ADAG | Adagene Inc. | 91.39M | 4.86% | 50,348 | 103.20K |
| 357 | ANEB | Anebulo Pharmaceuticals, Inc. | 90.39M | 25.71% | 86,314 | - |
| 358 | ZNTL | Zentalis Pharmaceuticals, Inc. | 89.22M | 4.20% | 1,115,584 | 26.87M |
| 359 | ORMP | Oramed Pharmaceuticals Inc. | 88.65M | 3.33% | 47,183 | 2.00M |
| 360 | WHWK | Whitehawk Therapeutics, Inc. | 88.57M | 1.08% | 25,278 | 27.78M |
| 361 | MGNX | MacroGenics, Inc. | 87.06M | 9.52% | 836,540 | 154.05M |
| 362 | ENTX | Entera Bio Ltd. | 86.81M | 2.69% | 13,910 | 223.00K |
| 363 | IVVD | Invivyd, Inc. | 86.73M | 0.25% | 664,723 | 36.69M |
| 364 | VERU | Veru Inc. | 85.55M | -1.08% | 1,544,069 | 16.89M |
| 365 | EXOZ | eXoZymes, Inc. | 85.35M | 4.62% | 2,930 | -700.00 |
| 366 | CLYM | Climb Bio, Inc. | 85.15M | 5.88% | 182,178 | - |
| 367 | TCRX | TScan Therapeutics, Inc. | 83.19M | 2.80% | 222,812 | 4.42M |
| 368 | EYEN | Eyenovia, Inc. | 80.75M | 49.81% | 4,643,505 | 67.06K |
| 369 | GUTS | Fractyl Health, Inc. | 80.32M | 3.80% | 293,734 | 60.00K |
| 370 | IGMS | IGM Biosciences, Inc. | 79.35M | 2.33% | 2,344,750 | 2.68M |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 78.48M | 4.90% | 1,923,265 | 283.10K |
| 372 | CBUS | Cibus, Inc. | 75.65M | 1.34% | 233,340 | 4.75M |
| 373 | EPIX | ESSA Pharma Inc. | 75.46M | -1.16% | 74,483 | - |
| 374 | VANI | Vivani Medical, Inc. | 75.24M | 0.79% | 65,823 | - |
| 375 | SRZN | Surrozen, Inc. | 74.84M | -0.79% | 2,342 | 11.64M |
| 376 | PYXS | Pyxis Oncology, Inc. | 74.34M | 11.11% | 591,627 | 16.15M |
| 377 | PLRX | Pliant Therapeutics, Inc. | 73.66M | 2.56% | 1,202,824 | - |
| 378 | OTLK | Outlook Therapeutics, Inc. | 73.28M | 8.23% | 984,296 | - |
| 379 | QNCX | Quince Therapeutics, Inc. | 72.75M | 5.26% | 311,073 | - |
| 380 | ARMP | Armata Pharmaceuticals, Inc. | 70.22M | 2.65% | 2,881 | 4.70M |
| 381 | GNTA | Genenta Science S.p.A. | 69.50M | -0.52% | 22,063 | - |
| 382 | ZURA | Zura Bio Limited | 69.30M | 6.67% | 435,818 | - |
| 383 | ABOS | Acumen Pharmaceuticals, Inc. | 68.75M | 2.25% | 167,120 | - |
| 384 | ONCY | Oncolytics Biotech Inc. | 68.42M | 5.00% | 3,079,473 | - |
| 385 | IMUX | Immunic, Inc. | 68.32M | 3.27% | 784,511 | - |
| 386 | IMMX | Immix Biopharma, Inc. | 67.12M | 10.05% | 218,586 | - |
| 387 | STRO | Sutro Biopharma, Inc. | 64.53M | 12.35% | 985,468 | 66.43M |
| 388 | ADAP | Adaptimmune Therapeutics plc | 64.25M | 4.53% | 403,614 | 179.64M |
| 389 | IKNA | Ikena Oncology, Inc. | 63.22M | -0.76% | 38,781 | - |
| 390 | QNTM | Quantum BioPharma Ltd. | 62.85M | -0.83% | 225,547 | - |
| 391 | MNOV | MediciNova, Inc. | 62.78M | 0.79% | 10,529 | - |
| 392 | INMB | INmune Bio, Inc. | 62.74M | 12.92% | 5,926,607 | 50.00K |
| 393 | CLSD | Clearside Biomedical, Inc. | 62.63M | 1.66% | 88,652 | 3.76M |
| 394 | ANRO | Alto Neuroscience, Inc. | 62.27M | 3.60% | 190,128 | - |
| 395 | RPTX | Repare Therapeutics Inc. | 61.76M | 1.41% | 75,726 | 1.07M |
| 396 | SER | Serina Therapeutics, Inc. | 61.20M | 1.99% | 2,527 | 51.00K |
| 397 | MGX | Metagenomi, Inc. | 60.18M | 6.27% | 658,277 | 45.26M |
| 398 | CNTB | Connect Biopharma Holdings Limited | 60.01M | 1.89% | 64,480 | 26.03M |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 59.96M | 7.87% | 1,037,333 | 7.18M |
| 400 | VTGN | Vistagen Therapeutics, Inc. | 59.48M | 1.49% | 179,320 | 486.00K |
| 401 | IRD | Opus Genetics, Inc. | 59.06M | 5.33% | 341,408 | 13.65M |
| 402 | UNCY | Unicycive Therapeutics, Inc. | 58.65M | -5.31% | 929,183 | - |
| 403 | PDSB | PDS Biotechnology Corporation | 58.05M | 4.10% | 644,669 | - |
| 404 | ICCC | ImmuCell Corporation | 57.75M | -3.47% | 3,302 | 27.30M |
| 405 | SNTI | Senti Biosciences, Inc. | 57.64M | 0.91% | 136,417 | - |
| 406 | MAIA | MAIA Biotechnology, Inc. | 57.58M | -1.04% | 322,870 | - |
| 407 | NRXP | NRx Pharmaceuticals, Inc. | 57.40M | 6.07% | 164,264 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 57.15M | 4.76% | 439,255 | - |
| 409 | CNTX | Context Therapeutics Inc. | 56.68M | 0.69% | 95,963 | - |
| 410 | OSTX | OS Therapies Incorporated | 56.67M | -1.04% | 254,363 | - |
| 411 | ANL | Adlai Nortye Ltd. | 55.96M | 1.11% | 296 | 1.94M |
| 412 | IFRX | InflaRx N.V. | 54.94M | 1.38% | 150,979 | 140.24K |
| 413 | FBIO | Fortress Biotech, Inc. | 54.11M | 0.55% | 86,167 | 57.78M |
| 414 | ATHE | Alterity Therapeutics Limited | 53.94M | 2.25% | 9,509 | 2.30M |
| 415 | AVTX | Avalo Therapeutics, Inc. | 53.49M | 2.07% | 554,702 | 441.00K |
| 416 | CUE | Cue Biopharma, Inc. | 52.14M | 2.91% | 225,482 | 7.99M |
| 417 | ACET | Adicet Bio, Inc. | 50.78M | 0.47% | 363,829 | - |
| 418 | ABVC | ABVC BioPharma, Inc. | 50.38M | 28.10% | 1,171,455 | 508.38K |
| 419 | ATRA | Atara Biotherapeutics, Inc. | 49.18M | 5.77% | 31,148 | 199.73M |
| 420 | CELU | Celularity Inc. | 48.62M | -0.98% | 20,210 | 54.22M |
| 421 | IPA | ImmunoPrecise Antibodies Ltd. | 48.51M | -2.75% | 757,610 | 16.58M |
| 422 | CRVO | CervoMed Inc. | 48.39M | -6.24% | 222,393 | 9.31M |
| 423 | GANX | Gain Therapeutics, Inc. | 48.33M | 4.14% | 302,349 | - |
| 424 | RENB | Renovaro Inc. | 48.07M | 2.68% | 823,987 | - |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 48.01M | 1.90% | 174,299 | 1.14M |
| 426 | APLT | Applied Therapeutics, Inc. | 47.90M | 5.72% | 2,060,223 | 265.00K |
| 427 | KLRS | Kalaris Therapeutics, Inc. | 47.88M | -0.78% | 15,106 | - |
| 428 | IPSC | Century Therapeutics, Inc. | 47.82M | 2.85% | 342,795 | 114.90M |
| 429 | RNXT | RenovoRx, Inc. | 47.54M | 2.36% | 87,074 | 240.00K |
| 430 | DTIL | Precision BioSciences, Inc. | 47.24M | 3.15% | 170,521 | 51.14M |
| 431 | ADVM | Adverum Biotechnologies, Inc. | 47.21M | -0.88% | 115,012 | 1.00M |
| 432 | ANVS | Annovis Bio, Inc. | 46.38M | 2.15% | 286,080 | - |
| 433 | PRLD | Prelude Therapeutics Incorporated | 45.85M | 1.50% | 60,442 | 7.00M |
| 434 | NRSN | NeuroSense Therapeutics Ltd. | 45.58M | - | 115,480 | - |
| 435 | ALGS | Aligos Therapeutics, Inc. | 44.70M | -1.08% | 52,325 | 3.27M |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 44.61M | 5.93% | 409,667 | 81.00K |
| 437 | MURA | Mural Oncology plc | 43.34M | 0.40% | 102,592 | - |
| 438 | PLUR | Pluri Inc. | 42.43M | 11.59% | 32,465 | 1.03M |
| 439 | GRCE | Grace Therapeutics, Inc. | 41.76M | 1.86% | 50,362 | - |
| 440 | STTK | Shattuck Labs, Inc. | 40.57M | 3.85% | 157,710 | 4.61M |
| 441 | ACRV | Acrivon Therapeutics, Inc. | 40.45M | 4.88% | 546,093 | - |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 40.26M | 6.88% | 112,653 | 142.13M |
| 443 | BRNS | Barinthus Biotherapeutics plc | 40.04M | 10.28% | 24,902 | 14.97M |
| 444 | PEPG | PepGen Inc. | 39.59M | 11.01% | 310,291 | - |
| 445 | JUNS | Jupiter Neurosciences, Inc. | 39.39M | 17.82% | 1,118,280 | - |
| 446 | ARTV | Artiva Biotherapeutics, Inc. | 38.74M | 3.92% | 128,868 | 251.00K |
| 447 | ITRM | Iterum Therapeutics plc | 38.72M | -0.68% | 445,660 | - |
| 448 | KLTO | Klotho Neurosciences, Inc. | 38.67M | 12.26% | 5,703,943 | - |
| 449 | XCUR | Exicure, Inc. | 37.65M | -2.30% | 84,667 | 500.00K |
| 450 | AKTX | Akari Therapeutics, Plc | 37.16M | -0.86% | 35,660 | - |
| 451 | XLO | Xilio Therapeutics, Inc. | 35.89M | - | 147,327 | 9.27M |
| 452 | PYPD | PolyPid Ltd. | 35.57M | -1.13% | 84,236 | - |
| 453 | LVTX | LAVA Therapeutics N.V. | 35.25M | 1.52% | 19,864 | 4.99M |
| 454 | TELO | Telomir Pharmaceuticals, Inc. | 35.12M | -7.09% | 268,707 | - |
| 455 | MRSN | Mersana Therapeutics, Inc. | 34.86M | 0.25% | 2,234,261 | 34.01M |
| 456 | LTRN | Lantern Pharma Inc. | 34.30M | 0.95% | 44,943 | - |
| 457 | RADX | Radiopharm Theranostics Limited | 34.18M | -5.30% | 17,273 | 204.61K |
| 458 | RNTX | Rein Therapeutics Inc. | 34.12M | 6.21% | 102,136 | - |
| 459 | KZR | Kezar Life Sciences, Inc. | 32.80M | 2.05% | 35,785 | - |
| 460 | ANTX | AN2 Therapeutics, Inc. | 32.74M | 3.33% | 66,694 | - |
| 461 | KALA | KALA BIO, Inc. | 32.58M | 4.34% | 52,717 | - |
| 462 | OKUR | OnKure Therapeutics, Inc. | 32.42M | - | 87,120 | - |
| 463 | ESLA | Estrella Immunopharma, Inc. | 31.86M | 2.35% | 9,306 | - |
| 464 | RANI | Rani Therapeutics Holdings, Inc. | 30.60M | 3.56% | 128,384 | 1.20M |
| 465 | PBM | Psyence Biomedical Ltd. | 30.19M | 5.81% | 35,736 | - |
| 466 | TPST | Tempest Therapeutics, Inc. | 29.14M | 3.33% | 77,463 | - |
| 467 | INKT | MiNK Therapeutics, Inc. | 28.58M | -2.32% | 1,378 | - |
| 468 | DYAI | Dyadic International, Inc. | 28.29M | -3.09% | 330,972 | 3.55M |
| 469 | CAMP | Camp4 Therapeutics Corporation | 27.21M | 0.74% | 45,376 | 1.51M |
| 470 | OSRH | OSR Holdings, Inc. | 26.79M | -7.95% | 97,979 | -148.95K |
| 471 | ENLV | Enlivex Therapeutics Ltd. | 26.76M | 0.89% | 33,878 | - |
| 472 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 26.18M | 4.22% | 3,099,376 | - |
| 473 | COEP | Coeptis Therapeutics Holdings, Inc. | 26.09M | 0.47% | 26,092 | 62.87K |
| 474 | IGC | IGC Pharma, Inc. | 25.75M | 1.15% | 195,323 | 1.27M |
| 475 | PASG | Passage Bio, Inc. | 25.25M | 6.86% | 361,682 | - |
| 476 | VYNE | VYNE Therapeutics Inc. | 25.16M | -14.69% | 2,638,783 | 605.00K |
| 477 | PULM | Pulmatrix, Inc. | 24.87M | 3.03% | 31,694 | 1.92M |
| 478 | GDTC | CytoMed Therapeutics Limited | 24.49M | -2.22% | 2,720 | 368.84K |
| 479 | CVKD | Cadrenal Therapeutics, Inc. | 24.47M | 6.60% | 47,754 | - |
| 480 | MLEC | Moolec Science SA | 24.12M | -3.99% | 1,887 | 7.83M |
| 481 | FBLG | FibroBiologics, Inc. | 23.95M | 1.60% | 360,028 | - |
| 482 | ALXO | ALX Oncology Holdings Inc. | 23.78M | 2.70% | 273,655 | - |
| 483 | BOLD | Boundless Bio, Inc. | 23.73M | - | 47,119 | - |
| 484 | OVID | Ovid Therapeutics Inc. | 23.50M | 4.59% | 633,670 | 548.00K |
| 485 | LSTA | Lisata Therapeutics, Inc. | 23.47M | -4.55% | 6,403 | 1.00M |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 23.47M | 10.53% | 2,300,916 | - |
| 487 | BCAB | BioAtla, Inc. | 23.28M | 2.05% | 353,126 | 11.00M |
| 488 | NRXS | NeurAxis, Inc. | 22.96M | 1.26% | 43,926 | 2.93M |
| 489 | GBIO | Generation Bio Co. | 22.65M | 5.59% | 696,267 | 24.56M |
| 490 | ELEV | Elevation Oncology, Inc. | 22.44M | 2.77% | 1,438,258 | - |
| 491 | CALC | CalciMedica, Inc. | 22.36M | 2.56% | 46,754 | - |
| 492 | NNVC | NanoViricides, Inc. | 22.34M | -0.71% | 140,791 | - |
| 493 | CMMB | Chemomab Therapeutics Ltd. | 22.04M | -0.86% | 139,184 | - |
| 494 | DARE | Daré Bioscience, Inc. | 21.24M | 1.27% | 12,352 | 25.91K |
| 495 | FGEN | FibroGen, Inc. | 21.22M | -0.38% | 72,672 | 7.00M |
| 496 | SLGL | Sol-Gel Technologies Ltd. | 20.80M | 1.84% | 527 | 12.10M |
| 497 | CGTX | Cognition Therapeutics, Inc. | 20.78M | 7.33% | 1,626,450 | - |
| 498 | CASI | CASI Pharmaceuticals, Inc. | 20.61M | 0.02% | 72,528 | 31.37M |
| 499 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.14M | -1.69% | 14,843 | - |
| 500 | RLMD | Relmada Therapeutics, Inc. | 19.95M | -2.43% | 185,365 | - |
| 501 | BCTX | BriaCell Therapeutics Corp. | 19.83M | 2.45% | 199,671 | - |
| 502 | LGVN | Longeveron Inc. | 19.51M | 1.56% | 80,172 | 2.23M |
| 503 | LSB | LakeShore Biopharma Co., Ltd | 19.46M | -2.86% | 2,650 | 79.42M |
| 504 | BLRX | BioLineRx Ltd. | 18.95M | 1.77% | 35,644 | 22.34M |
| 505 | CING | Cingulate Inc. | 18.43M | 4.83% | 50,156 | - |
| 506 | CRIS | Curis, Inc. | 18.31M | -18.60% | 1,124,503 | 11.20M |
| 507 | BIVI | BioVie Inc. | 17.99M | 4.23% | 215,348 | - |
| 508 | MRKR | Marker Therapeutics, Inc. | 17.76M | 3.97% | 36,388 | 5.70M |
| 509 | QTTB | Q32 Bio Inc. | 17.56M | - | 51,207 | - |
| 510 | CARM | Carisma Therapeutics, Inc. | 17.55M | 3.73% | 791,076 | 19.96M |
| 511 | IMNN | Imunon, Inc. | 17.04M | 2.41% | 705,069 | - |
| 512 | LEXX | Lexaria Bioscience Corp. | 16.66M | 3.44% | 61,933 | 525.92K |
| 513 | LPCN | Lipocine Inc. | 16.64M | -2.51% | 24,080 | 3.67M |
| 514 | SABS | SAB Biotherapeutics, Inc. | 16.45M | 0.57% | 5,713 | 377.84K |
| 515 | CLGN | CollPlant Biotechnologies Ltd. | 16.27M | 5.19% | 71,106 | 2.47M |
| 516 | MEIP | MEI Pharma, Inc. | 15.99M | 1.69% | 13,370 | - |
| 517 | HOTH | Hoth Therapeutics, Inc. | 15.85M | -1.64% | 275,324 | - |
| 518 | HOOK | HOOKIPA Pharma Inc. | 15.71M | -0.80% | 65,945 | 9.35M |
| 519 | PSTV | Plus Therapeutics, Inc. | 15.67M | -0.94% | 6,383,763 | 5.21M |
| 520 | EVAX | Evaxion A/S | 15.60M | -0.40% | 59,639 | 3.29M |
| 521 | COCP | Cocrystal Pharma, Inc. | 15.36M | 1.34% | 6,528 | - |
| 522 | ALLR | Allarity Therapeutics, Inc. | 15.08M | -3.85% | 308,655 | - |
| 523 | LYRA | Lyra Therapeutics, Inc. | 14.88M | 4.61% | 128,832 | 1.19M |
| 524 | EDSA | Edesa Biotech, Inc. | 14.82M | 3.94% | 25,983 | - |
| 525 | PMN | ProMIS Neurosciences, Inc. | 14.64M | -8.35% | 193,708 | - |
| 526 | ERNA | Ernexa Therapeutics Inc. | 14.58M | 8.79% | 78,929 | 535.00K |
| 527 | CANF | Can-Fite BioPharma Ltd. | 14.17M | -0.96% | 57,056 | 674.00K |
| 528 | SYBX | Synlogic, Inc. | 14.04M | 1.69% | 3,653 | 8.00K |
| 529 | ASBP | Aspire Biopharma Holdings, Inc. | 13.95M | -8.00% | 796,252 | - |
| 530 | NEUP | Neuphoria Therapeutics Inc. | 13.44M | 1.85% | 43,410 | 15.66M |
| 531 | RLYB | Rallybio Corporation | 13.44M | -2.24% | 105,709 | 848.00K |
| 532 | PRTG | Portage Biotech Inc. | 13.31M | -0.85% | 18,197 | - |
| 533 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 13.14M | 242.98% | 129,873,476 | 1.00M |
| 534 | MTVA | MetaVia Inc. | 12.96M | 1.82% | 58,655 | - |
| 535 | CVM | CEL-SCI Corporation | 12.94M | 6.33% | 231,197 | - |
| 536 | EVGN | Evogene Ltd. | 12.10M | 1.49% | 106,137 | 6.77M |
| 537 | NERV | Minerva Neurosciences, Inc. | 12.10M | 3.59% | 5,615 | - |
| 538 | NXTC | NextCure, Inc. | 12.01M | -1.77% | 118,700 | - |
| 539 | IBIO | iBio, Inc. | 12.00M | -1.32% | 964,656 | 375.00K |
| 540 | LPTX | Leap Therapeutics, Inc. | 11.93M | -2.80% | 292,575 | - |
| 541 | BRTX | BioRestorative Therapies, Inc. | 11.93M | -2.45% | 76,766 | 391.00K |
| 542 | PHIO | Phio Pharmaceuticals Corp. | 11.90M | - | 115,256 | - |
| 543 | ATHA | Athira Pharma, Inc. | 11.76M | 0.40% | 139,544 | - |
| 544 | ABP | Abpro Holdings, Inc. | 11.72M | 0.05% | 859,231 | 183.00K |
| 545 | KAPA | Kairos Pharma, Ltd. | 11.71M | -0.71% | 703,211 | - |
| 546 | BTAI | BioXcel Therapeutics, Inc. | 11.69M | -2.03% | 221,897 | 1.85M |
| 547 | SNSE | Sensei Biotherapeutics, Inc. | 11.68M | 4.69% | 8,680 | - |
| 548 | PHGE | BiomX Inc. | 11.52M | -3.32% | 168,568 | - |
| 549 | XFOR | X4 Pharmaceuticals, Inc. | 11.46M | 6.45% | 701,260 | 31.36M |
| 550 | ACXP | Acurx Pharmaceuticals, Inc. | 11.43M | -0.88% | 573,892 | - |
| 551 | EQ | Equillium, Inc. | 11.38M | 1.11% | 152,724 | 30.41M |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 11.33M | -1.50% | 12,615 | 3.64M |
| 553 | APVO | Aptevo Therapeutics Inc. | 11.27M | 3.05% | 169,284 | - |
| 554 | TAOX | TAO Synergies Inc. | 11.23M | -3.23% | 342,172 | - |
| 555 | BCDA | BioCardia, Inc. | 10.79M | 4.20% | 26,555 | 3.00K |
| 556 | CSCI | COSCIENS Biopharma Inc. | 10.64M | 0.87% | 2,601 | 9.03M |
| 557 | CYCN | Cyclerion Therapeutics, Inc. | 10.59M | 6.45% | 141,823 | 2.08M |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 10.19M | 3.83% | 33,148 | 451.00K |
| 559 | TCRT | Alaunos Therapeutics, Inc. | 10.01M | 7.89% | 46,054 | 11.00K |
| 560 | IMRN | Immuron Limited | 9.84M | - | 8,024 | 4.05M |
| 561 | GTBP | GT Biopharma, Inc. | 9.75M | -8.94% | 85,593 | - |
| 562 | AEON | AEON Biopharma, Inc. | 9.50M | 5.37% | 262,462 | - |
| 563 | APRE | Aprea Therapeutics, Inc. | 9.40M | 3.03% | 33,450 | 1.28M |
| 564 | BCLI | Brainstorm Cell Therapeutics Inc. | 9.29M | 5.41% | 282,824 | - |
| 565 | DWTX | Dogwood Therapeutics, Inc. | 9.23M | -2.42% | 36,107 | - |
| 566 | ICU | SeaStar Medical Holding Corporation | 9.04M | 15.46% | 19,274,159 | 428.00K |
| 567 | CHRO | Channel Therapeutics Corporation | 8.90M | - | - | - |
| 568 | KPRX | Kiora Pharmaceuticals, Inc. | 8.71M | 2.84% | 15,745 | 20.00K |
| 569 | CLRB | Cellectar Biosciences, Inc. | 8.57M | -2.67% | 212,097 | - |
| 570 | MBRX | Moleculin Biotech, Inc. | 8.37M | 7.09% | 2,893,075 | - |
| 571 | TSBX | Turnstone Biologics Corp. | 8.33M | 2.86% | 349,275 | - |
| 572 | IBO | Impact BioMedical Inc. | 8.15M | 4.85% | 1,168,274 | - |
| 573 | TRAW | Traws Pharma, Inc. | 8.12M | - | 44,967 | 227.00K |
| 574 | NLSP | NLS Pharmaceutics AG | 8.12M | -10.14% | 448,399 | - |
| 575 | CLDI | Calidi Biotherapeutics, Inc. | 7.86M | 1.70% | 544,055 | - |
| 576 | GNPX | Genprex, Inc. | 7.83M | 1.12% | 1,161,518 | - |
| 577 | PMCB | PharmaCyte Biotech, Inc. | 7.83M | - | 8,488 | - |
| 578 | ADXN | Addex Therapeutics Ltd | 7.69M | -0.76% | 14,879 | 278.51K |
| 579 | INTS | Intensity Therapeutics, Inc. | 7.52M | -2.66% | 501,110 | - |
| 580 | INAB | IN8bio, Inc. | 7.44M | 4.35% | 209,401 | - |
| 581 | KZIA | Kazia Therapeutics Limited | 7.36M | -0.75% | 11,734 | 1.55M |
| 582 | HCWB | HCW Biologics Inc. | 7.27M | 11.20% | 52,862 | 1.45M |
| 583 | APLM | Apollomics, Inc. | 7.24M | 2.50% | 426 | 198.00K |
| 584 | CELZ | Creative Medical Technology Holdings, Inc. | 6.94M | 1.89% | 14,306 | 14.00K |
| 585 | RNAZ | TransCode Therapeutics, Inc. | 6.91M | 10.53% | 23,107 | - |
| 586 | PPBT | Purple Biotech Ltd | 6.90M | 1.05% | 8,293 | - |
| 587 | SLXN | Silexion Therapeutics Corp | 6.78M | 0.39% | 63,530 | - |
| 588 | APM | Aptorum Group Limited | 6.63M | -0.80% | 11,041 | - |
| 589 | GOVX | GeoVax Labs, Inc. | 6.60M | -1.69% | 3,915,169 | 5.59M |
| 590 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.40M | 1.94% | 16,371 | 19.90K |
| 591 | INDP | Indaptus Therapeutics, Inc. | 6.18M | -3.23% | 7,426 | - |
| 592 | XBIO | Xenetic Biosciences, Inc. | 6.08M | 5.07% | 83,583 | 2.58M |
| 593 | ARTL | Artelo Biosciences, Inc. | 6.03M | 16.11% | 500,830 | - |
| 594 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.57M | 71.19% | 38,081,988 | - |
| 595 | KTTA | Pasithea Therapeutics Corp. | 5.57M | 1.80% | 78,415 | - |
| 596 | CYCC | Cyclacel Pharmaceuticals, Inc. | 5.52M | -26.29% | 4,304,806 | 14.00K |
| 597 | MBIO | Mustang Bio, Inc. | 5.43M | -39.51% | 2,877,136 | - |
| 598 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.33M | -1.84% | 3,922 | - |
| 599 | ADIL | Adial Pharmaceuticals, Inc. | 5.21M | 4.36% | 2,146,986 | - |
| 600 | CNSP | CNS Pharmaceuticals, Inc. | 5.13M | 10.43% | 434,325 | - |
| 601 | TTNP | Titan Pharmaceuticals, Inc. | 5.13M | 2.11% | 22,531 | - |
| 602 | UBX | Unity Biotechnology, Inc. | 5.13M | -13.14% | 3,276,630 | - |
| 603 | ATNF | 180 Life Sciences Corp. | 5.11M | 0.89% | 35,460 | - |
| 604 | PCSA | Processa Pharmaceuticals, Inc. | 4.94M | -5.75% | 4,387,517 | - |
| 605 | THAR | Tharimmune, Inc. | 4.84M | 2.25% | 17,195 | - |
| 606 | MTNB | Matinas BioPharma Holdings, Inc. | 4.78M | 4.09% | 75,437 | - |
| 607 | GLTO | Galecto, Inc. | 4.68M | 3.81% | 7,877 | - |
| 608 | CMND | Clearmind Medicine Inc. | 4.64M | 3.56% | 32,393 | - |
| 609 | SILO | Silo Pharma, Inc. | 4.53M | 2.46% | 92,925 | 72.10K |
| 610 | AZTR | Azitra, Inc. | 4.38M | -4.47% | 727,249 | 7.50K |
| 611 | DRMA | Dermata Therapeutics, Inc. | 4.25M | 4.12% | 88,869 | - |
| 612 | SNGX | Soligenix, Inc. | 4.11M | -10.64% | 963,753 | 2.34K |
| 613 | GLMD | Galmed Pharmaceuticals Ltd. | 4.09M | 1.69% | 143,897 | - |
| 614 | TOVX | Theriva Biologics, Inc. | 4.08M | 2.74% | 121,832 | - |
| 615 | VIVS | VivoSim Labs, Inc. | 3.98M | 5.52% | 38,811 | 144.00K |
| 616 | PLRZ | Polyrizon Ltd. | 3.84M | -0.55% | 170,184 | - |
| 617 | XRTX | XORTX Therapeutics Inc. | 3.75M | 12.07% | 112,680 | - |
| 618 | VRAX | Virax Biolabs Group Limited | 3.73M | 2.37% | 12,382 | 84.87K |
| 619 | ENSC | Ensysce Biosciences, Inc. | 3.73M | 1.34% | 38,011 | 6.22M |
| 620 | CERO | CERo Therapeutics Holdings, Inc. | 3.65M | 2.49% | 90,690 | - |
| 621 | NBY | NovaBay Pharmaceuticals, Inc. | 3.64M | 2.64% | 9,962 | 9.78M |
| 622 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.62M | 4.22% | 12,700 | 802.32K |
| 623 | PALI | Palisade Bio, Inc. | 3.50M | 2.01% | 123,431 | - |
| 624 | SPRC | SciSparc Ltd. | 3.48M | -0.86% | 343,117 | 1.31M |
| 625 | JAGX | Jaguar Health, Inc. | 3.40M | 2.80% | 104,725 | 11.55M |
| 626 | GRI | GRI Bio, Inc. | 3.40M | 5.84% | 126,934 | - |
| 627 | ZVSA | ZyVersa Therapeutics, Inc. | 3.34M | 7.53% | 435,802 | - |
| 628 | ELAB | PMGC Holdings Inc. | 3.18M | -0.86% | 526,664 | 2.45M |
| 629 | ENVB | Enveric Biosciences, Inc. | 3.09M | 1.63% | 34,169 | - |
| 630 | PTIX | Protagenic Therapeutics, Inc. | 3.02M | -1.69% | 235,044 | - |
| 631 | WINT | Windtree Therapeutics, Inc. | 2.82M | 40.00% | 78,677,481 | - |
| 632 | CDT | Conduit Pharmaceuticals Inc. | 2.67M | 0.36% | 94,443 | - |
| 633 | ADTX | Aditxt, Inc. | 2.65M | 3.31% | 4,467,046 | 55.32K |
| 634 | BDRX | Biodexa Pharmaceuticals Plc | 2.54M | 1.16% | 124,038 | 104.90K |
| 635 | ONCO | Onconetix, Inc. | 2.53M | 3.19% | 119,891 | 1.93M |
| 636 | QLGN | Qualigen Therapeutics, Inc. | 2.40M | -1.69% | 9,756 | - |
| 637 | ALZN | Alzamend Neuro, Inc. | 2.20M | 2.74% | 402,053 | - |
| 638 | SCNI | Scinai Immunotherapeutics Ltd. | 2.12M | -8.84% | 336,861 | 658.00K |
| 639 | ENTO | Entero Therapeutics, Inc. | 1.93M | 3.71% | 111,759 | - |
| 640 | SLRX | Salarius Pharmaceuticals, Inc. | 1.91M | 2.45% | 46,307 | - |
| 641 | TNFA | TNF Pharmaceuticals, Inc. | 1.64M | -6.23% | 3,291,865 | - |
| 642 | REVB | Revelation Biosciences, Inc. | 1.56M | -6.09% | 357,264 | - |
| 643 | OGEN | Oragenics, Inc. | 1.03M | -7.10% | 2,253,616 | - |
| 644 | NCNA | NuCana plc | 342.22K | -6.61% | 95,677,465 | - |